NCT03086642 2024-11-22
Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer
Columbia University
Phase 1 Completed
Clinical Trials
5 trialsNCT02509507 2024-08-06
MASTERKEY-318
Amgen
Phase 1/2 Completed
NCT03300544 2024-05-23
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT03256344 2024-05-14
Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases
Amgen
Phase 1 Completed
NCT00402025 2016-04-15
Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer
BioVex Limited
Phase 1 Completed